The deposition of hepatic triacylglycerol (TG) is a main cause of non-alcoholic fatty liver disease progressing to nonalcoholic steatohepatitis and cirrhosis.
The deposition of hepatic triacylglycerol (TG) is a main cause of non-alcoholic fatty liver disease progressing to nonalcoholic steatohepatitis and cirrhosis. 1) Non-alcoholic fatty liver disease is closely associated with abdominal obesity, a feature of metabolic syndrome, resulting from overeating high-fat and/or high-caloric foods.
2) The state of obesity is accompanied by the excessive storage of TG within adipocytes, and by an increased release of free fatty acids from hypertrophied adipocytes into the blood. The elevation of serum free fatty acids is involved in the accumulation of hepatocellular TG, because free fatty acids incorporated into hepatocytes are a main source of acyl chains of TG deposited as lipid droplets at the cytoplasm. 3) Regarding the sources of acyl chains of TG, a previous study showed that stimulation of rat hepatoma McA-RH7777 cells with oleate induces an increase in cellular TG bearing acyl chains derived from endogenous free fatty acids, and the hydrolysis of phospholipids with enhanced secretion of very low-density lipoproteins, 4) indicating that endogenous free fatty acids, probably derived from phospholipids, are also used for the formation of TG in hepatocytes exposed to exogenous free fatty acids. However, its precise mechanisms remain unclear.
Phospholipase A 2 (PLA 2 ) is an enzyme that catalyzes the hydrolysis of glycerophospholipids at the sn-2 position, generating free fatty acids and lysophospholipids. Several isozymes of intracellular PLA 2 s, such as group IVA, IVC, VIA, and VIB PLA 2 s, have been identified. 5, 6) Among them, group VIA PLA 2 , a Ca 2ϩ -independent cytosolic enzyme, has been suggested to contribute to oleate-induced secretion of TG as very low-density lipoproteins through the remodeling of acyl chains of phospholipids as a component of the lipoproteins in rat hepatoma McA-RH7777 cells, while this isozyme is not involved in oleate-induced accumulation of hepatocellular cytosolic TG. 4) In contrast to group VIA PLA 2 , group IVC PLA 2 is present as a membrane-bound form at the endoplasmic reticulum and mitochondria. [7] [8] [9] Previously, we reported that in human THP-1 monocytic cellderived macrophages, in which group IVC PLA 2 is expressed during the differentiation into macrophages, oxidized lowdensity lipoprotein-induced formation of cholesteryl ester is suppressed by methyl arachidonyl fluorophosphonate (MAFP) used as an inhibitor of group IV PLA 2 s, but not by bromoenol lactone used as an inhibitor of group VI PLA 2 s, 10) suggesting the possible involvement of group IVC PLA 2 in the supply of fatty acyl chains of cholesteryl ester. Considering this notion, it is possible that group IVC PLA 2 mediates the supply of endogenous free fatty acids utilized for the formation of TG in hepatocytes stimulated with exogenous free fatty acids. Group IVA PLA 2 , a Ca 2ϩ -dependent cytosolic enzyme, plays a pivotal role in the first step of the arachidonic acid cascade. 5) Our recent study of group IVA PLA 2 -knockout mice fed high-fat diets demonstrated that a deficiency of this enzyme protects mice against the high-fat diet-induced hepatocellular vacuolation and increase in hepatic TG content, 11) suggesting that group IVA PLA 2 is involved in the development of non-alcoholic fatty liver disease. However, mechanisms by which group IVA PLA 2 mediates hepatocellular TG deposition are not clear.
Taking the findings mentioned above into account, it is possible that intracellular PLA 2 s, especially group IVA and IVC PLA 2 s, are involved in the supply of endogenous free fatty acids utilized for the formation of TG in hepatocytes exposed to exogenous free fatty acids. In the present study, to examine this hypothesis, we determined whether the expression of the intracellular PLA 2 s is induced in human hepatoma Huh-7 cells upon stimulation with free fatty acids, and associated with the fatty acid-induced increase in cellu-lar TG.
MATERIALS AND METHODS
Materials Sodium oleate, sodium linoleate, and the antihuman b-actin antibody were from Sigma (St. Louis, MO, U.S.A.). MAFP, CAY10502, and bromoenol lactone were from Cayman Chemical (Ann Arbor, MI, U.S.A.), and used as an inhibitor of group IVC PLA 2 , 12) group IVA PLA 2 , 13) and group VIA and VIB PLA 2 s, 14) respectively. Dulbecco's modified Eagle's medium (DMEM) and phosphate-buffered saline (PBS) were from Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan). Chylomicrons were from ASSAYPRO (St. Charles, MO, U.S.A.). The horseradish peroxidase-conjugated anti-rabbit immunoglobulin G (IgG) antibody was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, U.S.A.). The affinity-purified rabbit polyclonal antibody against a peptide of group IVC PLA 2 was from Oriental Yeast Co., Ltd. (Tokyo, Japan). All other reagents were obtained from Wako Pure Chemical Industries (Osaka, Japan).
Cell Culture Human hepatoma Huh-7 cells (the Cell Resource Center for Biomedical Research, Tohoku University, Sendai, Japan) were maintained in DMEM supplemented with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 14 mM NaHCO 3 , 100 U/ml penicillin, and 100 mg/ml streptomycin at 37°C in humidified air containing 5% CO 2 . The cells were plated in 35-mm culture dishes at 3ϫ10 5 cells or 100-mm culture dishes at 2ϫ10 6 cells, cultured for 24 h, and placed in DMEM containing 2 mM L-glutamine and 14 mM NaHCO 3 (without fetal bovine serum and antibiotics). After being made quiescent for 24 h, the cells were placed in fresh DMEM containing 2 mM L-glutamine and 14 mM NaHCO 3 just before use.
Preparation of Free Fatty Acids As a stock solution of free fatty acids, a mixture of 150 mM NaCl, 24 mg/ml bovine serum albumin, and 4 mM of either oleate or linoleate was prepared. The mixture of each free fatty acid was diluted with 150 mM NaCl containing 24 mg/ml bovine serum albumin, which was also used as a vehicle, to obtain the desired concentrations. Under our experimental conditions where Huh-7 hepatocytes were stimulated with 100 or 200 mM of oleate or linoleate, the final concentration of bovine serum albumin was 1.2 mg/ml.
Measurement of Cellular TG Huh-7 hepatocytes (3ϫ10 5 cells) were treated with 10 mM of a PLA 2 inhibitor (MAFP, CAY10502, or bromoenol lactone) for 1 h, and then stimulated in the presence of that PLA 2 inhibitor with oleate, linoleate, or chylomicrons for 24 or 48 h as described in the figure legends. The cells were washed with PBS, and collected in lysis buffer (1% Triton X-100, 150 mM NaCl, 5 mM ethylene glycol bis(2-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA), 1 mM phenylmethanesulfonyl fluoride, 1 mg/ml aprotinin, 2 mg/ml leupeptin, 2 mg/ml pepstatin, and 20 mM Tris-HCl, pH 7.4). The cell lysate was subjected to the measurement of cellular TG with a commercial assay kit (Wako Pure Chemical Industries, Osaka, Japan). Reverse Transcription-Polymerase Chain Reaction (RT-PCR) The mRNA expression of group IVA, IVC, VIA, and VIB PLA 2 s was analyzed by RT-PCR. After stimulation of Huh-7 hepatocytes with free fatty acids or chylomicrons for 6 or 12 h, total RNA was extracted from the cells with ISOGEN (NIPPON GENE Co., Ltd., Tokyo, Japan). First-strand cDNA was generated from the total RNA in a reaction mixture containing random ninemers, deoxyribonucleotide triphosphate (dNTP), RNase inhibitor, and ReverTra Ace (TOYOBO Co., Ltd., Osaka, Japan). The resulting reaction mixture was subjected to PCR with AmpliTaq Gold (Applied Biosystems, Foster City, CA, U.S.A.) using 5Ј-GAG-TTTTGGGCGTTTCTGGT-3Ј (sense) and 5Ј-ACGGCAG-GTTAAATGTGAGC-3Ј (antisense) for group IVA PLA 2 , 5Ј-TCCGGGACAAGATAATGAGC-3Ј (sense) and 5Ј-ATGT-GTCACTCCATGCCTCA-3Ј (antisense) for group IVC PLA 2 , 5Ј-CTCGCCCATGAAGTTCTCTC-3Ј (sense) and 5Ј-GCCTTGATCATCTCCACGTT-3Ј (antisense) for group VIA PLA 2 , 5Ј-GCCATTAGAGCCTCATCTGC-3Ј (sense) and 5Ј-TCAGGAGGTAACAGGCCATC-3Ј (antisense) for group VIB PLA 2 , and 5Ј-GATCATTGCTCCTCCTGAGC-3Ј (sense) and 5Ј-CACCTTCACCGTTCCAGTTT-3Ј (antisense) for b-actin. Expression of b-actin was used as the internal standard. The PCR conditions were as follows: 94°C for 10 min; followed by 30 cycles (for b-actin) or 35 cycles (for PLA 2 isoforms) of 94°C for 60 s, 56°C for 60 s, and 72°C for 150 s. Products were resolved on 1.5% agarose gels and visualized with ethidium bromide. Representative results of three separate experiments are shown. To estimate the degree of mRNA expression of PLA 2 isoforms, the density of each band on a gel was analyzed with an NIH imageJ analysis software (developed at U.S. National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nihimage/). The results are expressed in arbitrary units. Each value represents the meanϮS.E.M. from three independent experiments.
Immunoblot Analysis Huh-7 hepatocytes (2ϫ10 6 cells) were stimulated with oleate or linoleate as described in the figure legends. The cells were washed with PBS, collected in lysis buffer, and subjected to the protein assay. The lysate was solubilized with a buffer (2% sodium dodecyl sulfate, 1 mM ethylenediaminetetraacetic acid (EDTA), 3 mM EGTA, 2% b-mercaptoethanol, 5% glycerol, 0.01% bromophenol blue, and 50 mM Tris-HCl, pH 6.8), and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a 7.5% gel. The separated proteins were transferred onto a nitrocellulose membrane. Antibodies against group IVC PLA 2 or b-actin were applied. The bound antibodies were visualized using a peroxidase-conjugated secondary antibody and enhanced chemiluminescence Western blotting detection reagents (GE Healthcare Biosciences, Piscataway, NJ, U.S.A.). Representative results of three separate experiments are shown.
DNA Construction and Transfection DNA construction and transfection group IVC PLA 2 cDNA, kindly provided from Dr. A. Yamashita (Teikyo University, Japan), was inserted into pTracerSV40 mammalian expression vector (Invitrogen, Carlsbad, CA, U.S.A.) at the multiple cloning sites, and the resultant plasmid was called pTrcG4C-WT. For construction of substitution mutant of group IVC PLA 2 in which serine at position 82 was substituted with alanine (pTrcG4C-S82A), PCR-based site-directed mutagenesis was carried out using the QuikChange TM site-directed mutagenesis kit (Stratagene, La Jolla, CA, U.S.A.) according to the manufacturer's instructions. pTrcG4C-WT was used as template DNA and the primers used for site-directed mutagenesis were as follows: 5Ј-TACCTCGCAGGGGTCGCTGGTTCCACTT-GGGCAATATCT-3Ј (sense), 5Ј-AGATATTGCCCAAGTG-GATCCAGCGACCCCTGCGAGGTA-3Ј (anti-sense). Sequences were confirmed by automated DNA sequencing. All fusion constructs were transformed into Escherichia coli JM109.
Huh-7 cells (5ϫ10 5 cells) in 35 mm-dishes were transfected with 1 mg of plasmid DNA (pTrc-empty vector, pTrcG4C-WT, or pTrcG4C-S82A) using 0.5 ml of Lipofectamine 2000 (Invitrogen) in serum-free Opti-MEM (Invitrogen) according to the manufacturer's instructions. At 72 h after the transfection, the cells were washed with PBS, collected in lysis buffer, and subjected to the immunoblot analysis and measurement of cellular TG levels.
Statistical Analysis Data were analyzed with Student's t-test. pϽ0.05 was considered statistically significant.
RESULTS
The deposition of TG induced by oleate or linoleate in Huh-7 hepatocytes is shown in Fig. 1 . The results indicate that stimulation with oleate or linoleate (100 or 200 mM) for 24 or 48 h increased the amount of cellular TG in a dose-and time-dependent manner. To examine the possible involvement of intracellular PLA 2 s in the fatty acid-induced deposition of TG, we determined mRNA levels of group IVA, IVC, VIA, and VIB PLA 2 s in fatty acid-stimulated Huh-7 hepatocytes. As shown in Figs. 2A and B, oleate (100 or 200 mM) induced the apparent expression of group IVC PLA 2 mRNA at 6 and 12 h after the stimulation. In contrast, no change in the mRNA levels of group IVA, VIA, or VIB PLA 2 was observed in the oleate-stimulated cells (Fig. 2A) . Furthermore, we confirmed that stimulation with oleate (100 or 200 mM) for 48 h increased the expression of group IVC PLA 2 , as estimated by immunoblotting, and an apparent increase in group IVC PLA 2 was induced at 24-48 h after stimulation with oleate (200 mM), as shown in Fig. 2C . These findings indicate that group IVC PLA 2 is expressed in response to oleate in Huh-7 hepatocytes.
To examine the possible involvement of group IVC PLA 2 in the accumulation of TG, we tested the effects of MAFP, used as an inhibitor of group IVC PLA 2 , on the oleateinduced TG deposition. As shown in Fig. 3 (400 mM, 1 h), in which MAFP or bromoenol lactone (an inhibitor of group VI PLA 2 s) had no effect on the oleateinduced accumulation of cytosolic TG. 4) Considering the time course of the protein expression of group IVC PLA 2 ( Fig. 2C) , these findings indicate that the inhibitory effect of MAFP occurs after group IVC PLA 2 is expressed upon stimulation with oleate. In contrast to MAFP, CAY10502 (10 mM), a specific group IVA PLA 2 inhibitor, or bromoenol lactone (10 mM) had no effect on the oleate (200 mM, 48 h)-induced deposition of TG under our experimental conditions (unstimulated cells, 27.0 mg/mg protein; oleate alone, 102.4 mg/mg protein; CAY10502ϩoleate, 97.6 mg/mg protein; bromoenol lactone, 94.2 mg/mg protein; the mean of two independent experiments performed in duplicate).
Stimulation with linoleate (100 or 200 mM) for 6 or 12 h also induced the expression of group IVC PLA 2 mRNA, but did not affect mRNA levels of group IVA, VIA, or VIB PLA 2 , as shown in Fig. 4A . Furthermore, linoleate (200 mM) induced the protein expression of group IVC PLA 2 with an apparent increase 24-48 h after the stimulation (Fig. 4B) . Figure 4C shows the effects of MAFP on the linoleate-induced deposition of TG. Similar to the case of oleate stimulation, in MAFP (10 mM)-treated Huh-7 hepatocytes, while no significant inhibition of the linoleate (200 mM)-induced deposition of TG was observed at 24 h, a partial inhibitory effect was observed at 48 h.
In addition to exogenous free fatty acids, excessive incorporation of lipoproteins, such as chylomicron remnants, into hepatocytes is also a cause of the accumulation of hepatocellular TG. We examined using chylomicrons whether lipoproteins containing TG induce the expression of group IVC PLA 2 . As shown in Fig. 5A , incubation with chylomicrons (0.5-2 mg/ml) for 24 h increased the amount of cellular TG (Fig. 5B) . These results indicate that chylomicrons induce the deposition of TG without expressing group IVC PLA 2 , suggesting no contribution of group IVC PLA 2 to the deposition. Consistent with this notion, pretreatment with MAFP (10 mM) had no effect on the deposition of TG in response to chylomicrons (2 mg/ml, 24 h), as shown in Fig. 5C .
To examine whether an increase in group IVC PLA 2 results in the deposition of cellular TG, we tested the effects of overexpression of wild-type group IVC PLA 2 and a catalytically inactive mutant of group IVC PLA 2 (S82A) 15) on cellular TG content in Huh-7 hepatocytes. As shown in Fig. 6A , we confirmed increases in wild-type group IVC PLA 2 and a mutant of group IVC PLA 2 in Huh-7 hepatocytes transiently transfected with pTrcG4C-WT and pTrcG4C-S82A, respectively, compared with the case of the transfection with pTrcempty vector, as estimated by immunoblotting. Under the conditions, cellular TG levels tended to be increased by the overexpression of wild-type group IVC PLA 2 , but not by a catalytic-site mutant of group IVC PLA 2 (Fig. 6B) .
DISCUSSION
Fatty liver occurs in parallel with the accumulation of hepatic TG. The amounts of hepatocellular TG are regulated by several exogenous factors including free fatty acids, chylomicron remnants, insulin, adipokines, and prostaglandins. Among these factors, exogenous free fatty acids have been shown to induce an increase in cellular TG bearing acyl chains derived from endogenous free fatty acids in addition to themselves in rat hepatoma McA-RH7777 cells.
4) The present study demonstrated the possible involvement of intracellular PLA 2 s, especially group IVC PLA 2 , in the deposition of cellular TG in hepatocytes exposed to exogenous free fatty acids.
Group IVC PLA 2 is constitutively and highly expressed in the heart and skeletal muscle, 16) and detected in monocytes. 17) In contrast, its expression in the liver is scarcely detectable. 16) In the present study, we found that the stimulation of Huh-7 hepatocytes with oleate or linoleate, which increased cellular TG levels, induced the expression of group IVC PLA 2 mRNA followed by the protein expression, but did not affect mRNA levels of group IVA, VIA, or VIB PLA 2 (Figs. 1, 2, 4) . This observation suggests that among the four intracellular PLA 2 s tested here, only group IVC PLA 2 is inducible in Huh-7 hepatocytes stimulated with free fatty acids. Our previous report showed that human THP-1 monocytic cells treated with a protein kinase C-activating phorbol ester to cause them to differentiate into macrophage-like cells, produced group IVA and IVC PLA 2 proteins.
10) Based on these findings, the molecular mechanisms responsible for the expression of group IVC PLA 2 seem to differ from those responsible for the expression of group IVA PLA 2 . However, further study is needed to clarify the intracellular factors involved in the expression of group IVC PLA 2 .
The present study demonstrated that an apparent group IVC PLA 2 protein was produced 24-48 h after stimulation with oleate or linoleate (Figs. 2, 4) , and further that MAFP, used as an inhibitor of group IVC PLA 2 , suppressed partially the deposition of TG induced by oleate or linoleate (Figs. 3,  4) . These findings suggest that the free fatty acid-induced deposition of TG is mediated in part by an increase in group IVC PLA 2 . This notion is consistent with the result that an increase in cellular TG induced by chylomicrons, which did not stimulate the expression of group IVC PLA 2 mRNA, was insensitive to MAFP (Fig. 5) . The pathway responsible for the deposition of TG induced by exogenous free fatty acids is triggered by the actions of acyl-CoA synthetase and diacylglycerol : acyl-CoA acyltransferase. 18) MAFP is reported to have no effect on the activity of acyl-CoA synthetase, 19) although it is unclear whether it affects the activity of diacylglycerol : acyl-CoA acyltransferase. We further showed here that MAFP had no effect on the oleate-and linoleate-induced deposition of TG at 24 h, despite suppressing it at 48 h (Figs.  3, 4) , indicating that MAFP did not exhibit inhibitory effects throughout the period of stimulation. Considering these findings, it is unlikely that the suppression by MAFP of free fatty acid-induced TG deposition at 48 h results from inhibition of diacylglycerol : acyl-CoA acyltransferase. The lack of inhibitory effects of MAFP on the deposition of TG 24 h after the stimulation may be ascribable to insufficient expression of group IVC PLA 2 . Regarding other intracellular PLA 2 s, we showed no change in mRNA levels of group IVA, VIA, or VIB PLA 2 in Huh-7 hepatocytes stimulated with oleate or linoleate. Furthermore, although MAFP acts on intracellular PLA 2 s other than group IVC PLA 2 , no inhibitory effect on the deposition of TG was observed after 24 h not only with oleate or linoleate, but also with chylomicrons that did not induce the expression of group IVC PLA 2 mRNA. These findings appear to indicate no involvement of group IVA, VIA, or VIB PLA 2 in the MAFP-inhibitable deposition of TG observed 48 h after the stimulation with oleate or linoleate. Consistent with this notion, it has been suggested that group VIA PLA 2 does not contribute to the deposition of cellular TG induced by exogenous oleate, but plays a role in the secretion of TG as very low-density lipoproteins in rat hepatoma McA-RH7777 cells. 4) In contrast, although we ob- Huh-7 hepatocytes were transfected with pTrc-empty vector (Vect.), pTrcG4C-WT (WT), or pTrcG4C-S82A (S82A). After being cultured for 72 h, the cells were lysed and subjected to the immunoblot analysis with anti-group IVC PLA 2 antibodies (A) and measurement of cellular TG levels (B).
served that neither the group IVA PLA 2 inhibitor CAY10502 nor the group VI PLA 2 inhibitor bromoenol lactone affected the oleate-induced deposition of TG at the concentration used, the present findings including this pharmacological result do not completely rule out the possible involvement of group IVA and VIB PLA 2 s in the MAFP-insensitive deposition of TG observed throughout the period of stimulation. At present, it is unclear whether the two isoforms mediate an increase in hepatocellular TG induced by exogenous free fatty acids. Taken together, based on the present results indicating the inducible expression of group IVC PLA 2 and the MAFPinhibitable deposition of TG in Huh-7 hepatocytes stimulated with oleate or linoleate, there is at least a possibility that after being expressed, group IVC PLA 2 is somehow associated with the deposition of TG in response to exogenous free fatty acids. This notion is supported by the present finding that cellular TG levels increased with the overexpression of wild-type group IVC PLA 2 but not of a catalytically inactive mutant of group IVC PLA 2 (S82A) (Fig. 6) , suggesting the necessary of PLA 2 activity for the increase in cellular TG.
Group IVA PLA 2 is a main enzyme that catalyzes the first step of the arachidonic acid cascade to generate lipid inflammatory mediators, such as prostaglandins. 5) In the present study, the group IVA PLA 2 inhibitor CAY10502 failed to suppress the deposition of TG induced by oleate in Huh-7 hepatocytes. However, our recent study demonstrated that in group IVA PLA 2 -knockout mice, a deficiency of this isoform alleviated high-fat diet-induced hepatic fat deposition and increases in the serum levels of liver damage marker aminotransferases, 11) suggesting that group IVA PLA 2 is involved in the high-fat diet-induced development of fatty liver damage. Taking the present results into account, group IVA PLA 2 might mediate the development of fatty liver through hepatic inflammation.
In summary, we demonstrated here that oleate and linoleate induced an increase in hepatocellular TG accompanied by the retarded expression of group IVC PLA 2 , and the deposition of TG after group IVC PLA 2 expression was sensitive to MAFP used as an inhibitor of the PLA 2 isoform in Huh-7 hepatocytes. The present findings suggest the possible involvement of increased group IVC PLA 2 in the deposition of hepatocellular TG induced by exogenous free fatty acids. Recently, Yamashita et al. clearly demonstrated that group IVC PLA 2 possesses activities of lysophospholipase and lysophospholipid acyltransferase in addition to PLA 2 activity. 20) However, it is still unclear whether such catalytic actions of group IVC PLA 2 are involved in the deposition of TG induced by free fatty acids, and whether free fatty acids released by group IVC PLA 2 are actually utilized for the deposition of TG. To further clarify the possible role of group IVC PLA 2 in the development of fatty liver, experiments with group IVC PLA 2 -knockdown Huh-7 hepatocytes are underway in our laboratory.
